biguanides has been researched along with Tuberculosis, Drug-Resistant in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, H | 1 |
| Wang, F | 1 |
| Zeng, G | 1 |
| Shen, L | 1 |
| Cheng, H | 1 |
| Huang, D | 1 |
| Wang, R | 1 |
| Rong, L | 1 |
| Chen, ZW | 1 |
1 other study available for biguanides and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.
Topics: Animals; Antitubercular Agents; Biguanides; Disease Models, Animal; DNA Replication; Drug Evaluation | 2016 |